Session-aware quotes · provider delays vary · Not financial advice
NeutralMEDIUM severitySupply Chain20d ago

AdaptHealth projects $490M-$520M 2026 EBITDA amid portfolio reset and west coast contract headwinds

Reported by Seeking Alpha · seekingalpha.com · August 4, 2026

$AHCO
Neutral read

AdaptHealth (AHCO) Q2 2026 earnings call recap: 16% organic growth, Diabetes divestiture, guidance reset, capitation & supplier risks.

What the tape says

What to watch: This report cites a concrete figure (16%) — compare it against the trailing trend before treating one data point as a turning point.

Amount
$490 million
Amount
$520 million
Change
16%

Market reaction today: $AHCO +0.00%

Tone and severity are deterministic keyword classification — not a prediction, a member vote, or a recommendation. Figures are extracted from the headline as published. Wook does not republish Seeking Alpha's reporting.

Your read

Discussion

No one has weighed in yet. Start the discussion on this story.

More coverage on these names

Headline and link are attributed to Seeking Alpha. Wook of Wall Street is an independent research tool and is not affiliated with Seeking Alpha. Nothing here is financial advice or a recommendation — research and educational content only.